These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3103281)

  • 1. Prolongation of murine cardiac allografts following treatment of graft recipients with monoclonal anti-L3T4 and Ly-2 antibodies.
    Mottram PL; Wheelahan J; Mirisklavos A; Clunie GJ; McKenzie IF
    Transplant Proc; 1987 Feb; 19(1 Pt 1):582-5. PubMed ID: 3103281
    [No Abstract]   [Full Text] [Related]  

  • 2. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL; Wheelahan J; McKenzie IF; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of anti-L3T4 and anti-LYT2 monoclonal antibody therapy on cardiac allograft survival in presensitized recipients.
    Madsen JC; Wood KJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1022. PubMed ID: 2495588
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolongation of islet isograft survival in diabetic NOD mice by anti-L3T4 and anti-LYT2 monoclonal antibodies.
    Matsuo S; Mullen Y; Wicker LS; Peterson LB; Nagata M; Tsunoda T; Clare-Salzler M
    Transplant Proc; 1990 Apr; 22(2):880-1. PubMed ID: 2109427
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of anti-L3T4 and anti-Lyt 2 monoclonal antibodies on murine cardiac allograft rejection.
    Madsen JC; Wood KJ; Morris PJ
    Transplant Proc; 1987 Oct; 19(5):3991-2. PubMed ID: 3313979
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolongation of murine cardiac allograft survival by the anti-interleukin-2 receptor monoclonal antibody AMT-13.
    Kirkman RL; Barrett LV; Koltun WA; Diamantstein T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):618-9. PubMed ID: 3274828
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts.
    Madsen JC; Peugh WN; Wood KJ; Morris PJ
    Transplantation; 1987 Dec; 44(6):849-52. PubMed ID: 3321596
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4.
    Wofsy D; Seaman WE
    J Immunol; 1987 May; 138(10):3247-53. PubMed ID: 3106478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression by anti-CD8 (Ly-2.1) MAb conjugated to idarubicin: studies in the mouse heart graft model.
    Mottram PL; Pietersz GA; Purcell LJ; Clunie GJ; McKenzie IF
    Transplant Proc; 1990 Oct; 22(5):2111-2. PubMed ID: 2120812
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-L3T4 monoclonal antibodies prolong survival of Ia-antigen disparate skin allografts.
    Holán V
    Folia Biol (Praha); 1988; 34(2):65-71. PubMed ID: 3294049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
    Merino J; Schurmans S; Luzuy S; Izui S; Vassalli P; Lambert PH
    J Immunol; 1987 Sep; 139(5):1426-31. PubMed ID: 3114366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of monoclonal anti-H-2Ld and anti-H-2Dd alloantibodies in the immunological enhancement of skin grafts and neonatal heart grafts in the mouse.
    Lems SP; Jacobs CW; Capel PJ; Koene RA
    J Immunol; 1987 Apr; 138(7):2082-7. PubMed ID: 3549896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M; Jendrisak G; Gamero J; Mohanakumar T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
    Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion.
    Nakakura EK; McCabe SM; Zheng B; Shorthouse RA; Scheiner TM; Blank G; Jardieu PM; Morris RE
    Transplantation; 1993 Feb; 55(2):412-7. PubMed ID: 8094583
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Lyt-2 mAb on murine skin graft survivals.
    Ichikawa T; Nakayama E; Uenaka A; Monden M; Okamura J; Mori T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):579-81. PubMed ID: 3547829
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
    Orosz CG; Bergese SD; Huang EH; Vanbuskirk AM
    Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
    [No Abstract]   [Full Text] [Related]  

  • 20. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.